Identification of women with an increased risk of developing radiation-induced breast cancer.
In the previous issue of Breast Cancer Research, Broeks and collaborators present the results of a study suggesting that germline mutations in BRCA1, BRCA2, ATM or CHEK2 may double the risk of radiation-induced contralateral breast cancer following radiotherapy for a first breast cancer. The assocation appeared to be strongest among women who were below the age of 40 at the time of their first breast cancer and among women who developed their second cancer 5 years or more after the first. While there were a number of methodological issues that might limit the conclusions drawn from this paper, this is one of several recent studies suggesting that carriers of pathogenic alleles in DNA repair and damage recognition genes may have an increased risk of breast cancer following exposure to ionising radiation, even at low doses. This finding has important implications for the protection of breast cancer patients and their close relatives. If confirmed, mutation carriers may wish to consider alternatives to X-ray for diagnostic purposes. The need for tailored cancer treatment strategies in carriers should also be evaluated carefully.
Cardis
Elisabeth
E
Hall
Janet
J
Tavtigian
Sean V
SV
D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000532:radiotherapy*; D004260:DNA Repair / Q000235:genetics; D005260:Female; D007839:Functional Laterality; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology*; D011877:Radionuclide Imaging; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D012727:Sex Characteristics